Serum albumin and risks of hospitalization and death: Findings from the Atherosclerosis Risk in Communities study.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
10 2021
Historique:
revised: 15 04 2021
received: 14 12 2020
accepted: 16 05 2021
pubmed: 24 7 2021
medline: 25 11 2021
entrez: 23 7 2021
Statut: ppublish

Résumé

To determine whether lower serum albumin in community-dwelling, older adults is associated with increased risk of hospitalization and death independent of pre-existing disease. Prospective cohort study of participants in the fifth visit of the Atherosclerosis Risk in Communities (ARIC) study. Baseline data were collected from 2011 to 2013. Follow-up was available to December 31, 2017. Replication was performed in Geisinger, a health system in rural Pennsylvania. For ARIC, four US communities: Washington County, Maryland; Forsyth County, North Carolina; Jackson, Mississippi; and suburbs of Minneapolis, Minnesota. A total of 4947 community-dwelling men and women aged 66 to 90 years. Serum albumin. Incident all-cause hospitalization and death. Among the 4947 participants, mean age was 75.5 years (SD: 5.12) and mean baseline serum albumin concentration was 4.05 g/dL (SD: 0.30). Over a median follow-up period of 4.42 years (interquartile interval: 4.16-5.05), 553 participants (11.2%) died and 2457 participants (49.7%) were hospitalized at least once. The total number of hospitalizations was 5725. In analyses adjusted for demographics and numerous clinical characteristics, including tobacco use, obesity, frailty, cardiovascular disease, kidney disease, diabetes C-reactive protein (CRP), cognitive status, alcohol use, medication use, respiratory disease, and systolic blood pressure, 1 g/dL lower baseline serum albumin concentration was associated with higher risk of both hospitalization (incidence rate ratio [IRR]: 1.58; 95% confidence interval [CI]: 1.36-1.82; p < 0.001) and death (hazard ratio [HR]: 1.67; 95% CI: 1.24-2.24; p < 0.001). Associations were weaker with older age but not different by frailty status or level of high-sensitivity CRP. Associations between serum albumin, hospitalizations, and death were also similar in a real-world cohort of primary care patients. Lower baseline serum albumin was significantly associated with increased risk of both all-cause hospitalization and death, independent of pre-existing disease. Older adults with low serum albumin should be considered a high-risk population and targeted for interventions to reduce the risk of adverse outcomes.

Identifiants

pubmed: 34298583
doi: 10.1111/jgs.17313
pmc: PMC8582595
mid: NIHMS1728918
doi:

Substances chimiques

Serum Albumin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2865-2876

Subventions

Organisme : NHLBI NIH HHS
ID : K24 HL152440
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK089174
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007024
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL155861
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004C
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001078
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003098
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01DK089174
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK106414
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005I
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society.

Références

Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Circulation. 2002 Dec 3;106(23):2919-24
pubmed: 12460872
J Am Geriatr Soc. 2000 Nov;48(11):1404-7
pubmed: 11083315
Lab Med. 2018 Oct 11;49(4):355-361
pubmed: 29790973
N Engl J Med. 1993 Sep 30;329(14):1001-6
pubmed: 8366899
Ann Epidemiol. 2020 May;45:40-46.e4
pubmed: 32371044
Am J Kidney Dis. 1995 Jul;26(1):220-8
pubmed: 7611256
Epidemiology. 1997 Jan;8(1):87-92
pubmed: 9116102
Ann Clin Biochem. 1985 May;22 ( Pt 3):304-9
pubmed: 4026190
Biomark Res. 2017 Nov 10;5:31
pubmed: 29152305
Kidney Int. 2016 Jul;90(1):164-71
pubmed: 27181999
J Clin Hypertens (Greenwich). 2012 Jul;14(7):407-14
pubmed: 22747612
J Am Soc Nephrol. 1993 Mar;3(9):1613-22
pubmed: 8507818
Br J Anaesth. 2000 Oct;85(4):599-610
pubmed: 11064620
Am J Kidney Dis. 1995 Jul;26(1):209-19
pubmed: 7611254
Ann Intern Med. 2020 Sep 15;173(6):426-435
pubmed: 32658569
J Clin Epidemiol. 1992 Mar;45(3):207-12
pubmed: 1569417
Hepatology. 2005 Jun;41(6):1211-9
pubmed: 15915465
Am J Med. 2017 Dec;130(12):1465.e11-1465.e19
pubmed: 28803138
Am J Kidney Dis. 1998 Jun;31(6):997-1006
pubmed: 9631845
Ann Clin Biochem. 2016 Jan;53(Pt 1):97-105
pubmed: 25673775
J Am Soc Nephrol. 1996 May;7(5):728-36
pubmed: 8738808
Am Heart J. 1992 Feb;123(2):507-13
pubmed: 1736588
Lancet. 1989 Dec 16;2(8677):1434-6
pubmed: 2574367
JAMA. 1994 Oct 5;272(13):1036-42
pubmed: 8089886
J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):382-388
pubmed: 27470301
J Am Geriatr Soc. 2017 Nov;65(11):2413-2417
pubmed: 28941287
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Am Soc Nephrol. 1996 Oct;7(10):2169-75
pubmed: 8915977
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Clin Invest. 1993 Apr;91(4):1582-9
pubmed: 8473501

Auteurs

Colleen M Shannon (CM)

Johns Hopkins Institute for Clinical and Translational Research, Johns Hopkins University, Baltimore, Maryland, USA.

Shoshana H Ballew (SH)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Natalie Daya (N)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Linda Zhou (L)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Alex R Chang (AR)

Kidney Health Research Institute, Geisinger Health, Danville, Pennsylvania, USA.

Yingying Sang (Y)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Josef Coresh (J)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Elizabeth Selvin (E)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.

Morgan E Grams (ME)

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH